Advertisement

Index by author

March 01, 1982; Volume 220,Issue 3

A

  1. Arbilla, S

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor.
      K G Lloyd, S Arbilla, K Beaumont, M Briley, G De Montis, B Scatton, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 672-677;

B

  1. Barry, W H

    1. Lack of interaction between digoxin and quinidine in cultured heart cells.
      J D Horowitz, W H Barry and T W Smith
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 488-493;

  2. Bartholini, G

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
      P Worms, H Depoortere, A Durand, P L Morselli, K G Lloyd and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 660-671;
    2. gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor.
      K G Lloyd, S Arbilla, K Beaumont, M Briley, G De Montis, B Scatton, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 672-677;
    3. gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas.
      B Scatton, B Zivkovic, J Dedek, K G Lloyd, J Constantinidis, R Tissot and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 678-688;
    4. gamma-Aminobutyric acid (GABA) receptor stimulation. IV. Effect of progabide (SL 76002) and other GABAergic agents on acetylcholine turnover in rat brain areas.
      B Scatton and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 689-695;

  3. Beaumont, K

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor.
      K G Lloyd, S Arbilla, K Beaumont, M Briley, G De Montis, B Scatton, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 672-677;

  4. Berkowitz, B A

    1. Lack of an opiate response to nitrous oxide in mice resistant to the activity-stimulating effects of morphine.
      M D Hynes and B A Berkowitz
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 499-503;

  5. Bochner, F

    1. In vivo and in vitro studies on the binding of salicylate to human plasma proteins: evidence for one type of binding site.
      B E Cham, F Bochner, D M Imhoff, G Byrne and M Gunsberg
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 648-653;

  6. Braselton, W E

    1. Effects of vanadate on organic ion accumulation in rat renal cortical slices.
      J H Smith, W E Braselton, S R Tonsager, G H Mayor and J B Hook
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 540-546;

  7. Briley, M

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor.
      K G Lloyd, S Arbilla, K Beaumont, M Briley, G De Montis, B Scatton, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 672-677;

  8. Browner, M

    1. Comparison of the antinociceptive effect of gamma-aminobutyric acid (GABA) agonists: evidence for a cholinergic involvement.
      D A Kendall, M Browner and S J Enna
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 482-487;

  9. Buckner, C K

    1. Pharmacological alteration of antigen-induced contraction of pulmonary arteries isolated from the actively sensitized guinea pig.
      J M Hand, J A Will and C K Buckner
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 526-535;

  10. Byrne, G

    1. In vivo and in vitro studies on the binding of salicylate to human plasma proteins: evidence for one type of binding site.
      B E Cham, F Bochner, D M Imhoff, G Byrne and M Gunsberg
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 648-653;

C

  1. Cham, B E

    1. In vivo and in vitro studies on the binding of salicylate to human plasma proteins: evidence for one type of binding site.
      B E Cham, F Bochner, D M Imhoff, G Byrne and M Gunsberg
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 648-653;

  2. Cochin, J

    1. Opiates and thermoregulation in mice. II. Effects of opiate antagonists.
      C E Rosow, J M Miller, J Poulsen-Burke and J Cochin
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 464-467;
    2. Opiates and thermoregulation in mice. III. Agonist-antagonists.
      C E Rosow, J M Miller, J Poulsen-Burke and J Cochin
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 468-475;

  3. Commissaris, R L

    1. Dispositional without functional tolerance to the hypothermic effects of pentobarbital in the rat.
      R L Commissaris, D R Semeyn and R H Rech
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 536-539;

  4. Connors, B W

    1. Effects of local anesthetic QX-314 on the membrane properties of hippocampal pyramidal neurons.
      B W Connors and D A Prince
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 476-481;

  5. Constantinidis, J

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas.
      B Scatton, B Zivkovic, J Dedek, K G Lloyd, J Constantinidis, R Tissot and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 678-688;

  6. Cook, C E

    1. Immunoassay of racemic drugs: a problem of enantioselective antisera and a solution.
      C E Cook, T P Seltzman, C R Tallent and J D Wooten
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 568-573;

  7. Cooper, S E

    1. Toxic effects of organohalide compounds on renal tubular cells in vivo and in vitro.
      W M Kluwe, F W Harrington and S E Cooper
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 597-603;

  8. Corey, E J

    1. Selective antagonism of prostaglandin F2 alpha-mediated vascular responses by N-dimethylamino substitution of prostaglandin F2 alpha.
      R B Stinger, T M Fitzpatrick, E J Corey, P W Ramwell, J C Rose and P A Kot
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 521-525;

  9. Costa, E

    1. Evidence for a gamma-aminobutyric acid (GABA) mediation in the benzodiazepine inhibition of the release of Met5-enkephalin elicited by depolarization.
      L G Harsing, H Y Yang and E Costa
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 616-620;

D

  1. Dedek, J

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas.
      B Scatton, B Zivkovic, J Dedek, K G Lloyd, J Constantinidis, R Tissot and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 678-688;

  2. De Montis, G

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor.
      K G Lloyd, S Arbilla, K Beaumont, M Briley, G De Montis, B Scatton, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 672-677;

  3. Depoortere, H

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
      P Worms, H Depoortere, A Durand, P L Morselli, K G Lloyd and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 660-671;

  4. Durand, A

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
      P Worms, H Depoortere, A Durand, P L Morselli, K G Lloyd and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 660-671;

E

  1. Echizen, H

    1. Long-term infusion of L-5-hydroxytryptophan increases brain serotonin turnover and decreases blood pressure in normotensive rats.
      H Echizen and C R Freed
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 579-584;

  2. Enna, S J

    1. Comparison of the antinociceptive effect of gamma-aminobutyric acid (GABA) agonists: evidence for a cholinergic involvement.
      D A Kendall, M Browner and S J Enna
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 482-487;

F

  1. Feldman, R D

    1. Differential competition by L-alpha-methyldopa metabolites for adrenergic receptors in rat forebrain.
      M R Goldberg, C S Tung, R D Feldman, H E Smith, J A Oates and D Robertson
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 552-560;

  2. Feldman, S

    1. Aminoglycosides induce a phospholipidosis in the renal cortex of the rat: an early manifestation of nephrotoxicity.
      S Feldman, M Y Wang and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 514-520;
    2. Ultrafiltration of gentamicin and netilmicin in vivo.
      E Pastoriza-Munoz, D Timmerman, S Feldman and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 604-608;

  3. Field, M

    1. Neurohumoral control of ileal electrolyte transport. I. Bombesin and related peptides.
      J F Kachur, R J Miller, M Field and J Rivier
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 449-455;
    2. Neurohumoral control of ileal electrolyte transport. II. Neurotensin and substance P.
      J F Kachur, R J Miller, M Field and J Rivier
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 456-463;

  4. Fitzpatrick, T M

    1. Selective antagonism of prostaglandin F2 alpha-mediated vascular responses by N-dimethylamino substitution of prostaglandin F2 alpha.
      R B Stinger, T M Fitzpatrick, E J Corey, P W Ramwell, J C Rose and P A Kot
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 521-525;

  5. Flórez, J

    1. Morphine, pentobarbital and naloxone in the ventral medullary chemosensitive areas: differential respiratory and cardiovascular effects.
      M A Hurlé, A Mediavilla and J Flórez
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 642-647;

  6. Freed, C R

    1. Long-term infusion of L-5-hydroxytryptophan increases brain serotonin turnover and decreases blood pressure in normotensive rats.
      H Echizen and C R Freed
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 579-584;

  7. Friedman, E

    1. Differential dose- and time-dependent effects of molindone on dopamine neurons of rat brain: mediation by irreversible inhibition of monoamine oxidase.
      E Meller and E Friedman
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 609-615;

G

  1. Goldberg, M R

    1. Differential competition by L-alpha-methyldopa metabolites for adrenergic receptors in rat forebrain.
      M R Goldberg, C S Tung, R D Feldman, H E Smith, J A Oates and D Robertson
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 552-560;

  2. Gunsberg, M

    1. In vivo and in vitro studies on the binding of salicylate to human plasma proteins: evidence for one type of binding site.
      B E Cham, F Bochner, D M Imhoff, G Byrne and M Gunsberg
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 648-653;

  3. Gurll, N J

    1. Naloxone without transfusion prolongs survival and enhances cardiovascular function in hypovolemic shock.
      N J Gurll, D G Reynolds, T Vargish and R Lechner
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 621-624;
    2. Naltrexone improves survival rate and cardiovascular function in canine hemorrhagic shock.
      N J Gurll, D G Reynolds, T Vargish and R Lechner
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 625-628;

H

  1. Hand, J M

    1. Pharmacological alteration of antigen-induced contraction of pulmonary arteries isolated from the actively sensitized guinea pig.
      J M Hand, J A Will and C K Buckner
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 526-535;

  2. Harrington, F W

    1. Toxic effects of organohalide compounds on renal tubular cells in vivo and in vitro.
      W M Kluwe, F W Harrington and S E Cooper
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 597-603;

  3. Harsing, L G

    1. Evidence for a gamma-aminobutyric acid (GABA) mediation in the benzodiazepine inhibition of the release of Met5-enkephalin elicited by depolarization.
      L G Harsing, H Y Yang and E Costa
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 616-620;

  4. Hook, J B

    1. Effects of vanadate on organic ion accumulation in rat renal cortical slices.
      J H Smith, W E Braselton, S R Tonsager, G H Mayor and J B Hook
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 540-546;
    2. Renal cortical accumulation of phenobarbital in rats and rabbits: lack of correlation with induction of renal microsomal monooxygenases.
      C H Kuo, G F Rush and J B Hook
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 547-551;

  5. Horowitz, J D

    1. Lack of interaction between digoxin and quinidine in cultured heart cells.
      J D Horowitz, W H Barry and T W Smith
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 488-493;

  6. Hurlé, M A

    1. Morphine, pentobarbital and naloxone in the ventral medullary chemosensitive areas: differential respiratory and cardiovascular effects.
      M A Hurlé, A Mediavilla and J Flórez
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 642-647;

  7. Hynes, M D

    1. Lack of an opiate response to nitrous oxide in mice resistant to the activity-stimulating effects of morphine.
      M D Hynes and B A Berkowitz
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 499-503;

I

  1. Imhoff, D M

    1. In vivo and in vitro studies on the binding of salicylate to human plasma proteins: evidence for one type of binding site.
      B E Cham, F Bochner, D M Imhoff, G Byrne and M Gunsberg
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 648-653;

J

  1. Jollow, D J

    1. Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity.
      V F Price and D J Jollow
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 504-513;

  2. Juskevich, J C

    1. The effects of morphine on calcium-regulated phosphorylation of synaptosomal cytosolic proteins from rat striatum.
      J P O'Callaghan, J C Juskevich and W Lovenberg
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 696-702;

K

  1. Kachur, J F

    1. Neurohumoral control of ileal electrolyte transport. I. Bombesin and related peptides.
      J F Kachur, R J Miller, M Field and J Rivier
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 449-455;
    2. Neurohumoral control of ileal electrolyte transport. II. Neurotensin and substance P.
      J F Kachur, R J Miller, M Field and J Rivier
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 456-463;

  2. Kaloyanides, G J

    1. Aminoglycosides induce a phospholipidosis in the renal cortex of the rat: an early manifestation of nephrotoxicity.
      S Feldman, M Y Wang and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 514-520;
    2. Ultrafiltration of gentamicin and netilmicin in vivo.
      E Pastoriza-Munoz, D Timmerman, S Feldman and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 604-608;

  3. Kato, R

    1. Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum.
      T Nakaki, T Nakadate, S Yamamoto and R Kato
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 637-641;

  4. Kendall, D A

    1. Comparison of the antinociceptive effect of gamma-aminobutyric acid (GABA) agonists: evidence for a cholinergic involvement.
      D A Kendall, M Browner and S J Enna
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 482-487;

  5. Khazan, N

    1. Differential electroencephalographic and behavioral cross tolerance to morphine and methadone in the l-alpha-acetylmethadol (LAAM)-maintained rat.
      S E Lukas, J E Moreton and N Khazan
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 561-567;

  6. Kluwe, W M

    1. Toxic effects of organohalide compounds on renal tubular cells in vivo and in vitro.
      W M Kluwe, F W Harrington and S E Cooper
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 597-603;

  7. Kot, P A

    1. Selective antagonism of prostaglandin F2 alpha-mediated vascular responses by N-dimethylamino substitution of prostaglandin F2 alpha.
      R B Stinger, T M Fitzpatrick, E J Corey, P W Ramwell, J C Rose and P A Kot
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 521-525;

  8. Kuo, C H

    1. Renal cortical accumulation of phenobarbital in rats and rabbits: lack of correlation with induction of renal microsomal monooxygenases.
      C H Kuo, G F Rush and J B Hook
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 547-551;

L

  1. Langer, S Z

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor.
      K G Lloyd, S Arbilla, K Beaumont, M Briley, G De Montis, B Scatton, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 672-677;

  2. Lau, C

    1. Maturation of sympathetic neurotransmission in the rat heart. VIII. Slowed development of noradrenergic synapses resulting from hypothyroidism.
      C Lau and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 629-636;

  3. Leander, J D

    1. Opioid and nonopioid behavioral effects of methadone isomers.
      J D Leander and P E McCleary
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 592-596;

  4. Lechner, R

    1. Naloxone without transfusion prolongs survival and enhances cardiovascular function in hypovolemic shock.
      N J Gurll, D G Reynolds, T Vargish and R Lechner
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 621-624;
    2. Naltrexone improves survival rate and cardiovascular function in canine hemorrhagic shock.
      N J Gurll, D G Reynolds, T Vargish and R Lechner
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 625-628;

  5. Lloyd, K G

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
      P Worms, H Depoortere, A Durand, P L Morselli, K G Lloyd and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 660-671;
    2. gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor.
      K G Lloyd, S Arbilla, K Beaumont, M Briley, G De Montis, B Scatton, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 672-677;
    3. gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas.
      B Scatton, B Zivkovic, J Dedek, K G Lloyd, J Constantinidis, R Tissot and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 678-688;

  6. Löscher, W

    1. Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse.
      H Nau and W Löscher
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 654-659;

  7. Lovenberg, W

    1. The effects of morphine on calcium-regulated phosphorylation of synaptosomal cytosolic proteins from rat striatum.
      J P O'Callaghan, J C Juskevich and W Lovenberg
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 696-702;

  8. Ludens, J H

    1. Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine.
      G R Slizgi and J H Ludens
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 585-591;

  9. Lukas, S E

    1. Differential electroencephalographic and behavioral cross tolerance to morphine and methadone in the l-alpha-acetylmethadol (LAAM)-maintained rat.
      S E Lukas, J E Moreton and N Khazan
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 561-567;

M

  1. Mayor, G H

    1. Effects of vanadate on organic ion accumulation in rat renal cortical slices.
      J H Smith, W E Braselton, S R Tonsager, G H Mayor and J B Hook
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 540-546;

  2. McCleary, P E

    1. Opioid and nonopioid behavioral effects of methadone isomers.
      J D Leander and P E McCleary
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 592-596;

  3. Mediavilla, A

    1. Morphine, pentobarbital and naloxone in the ventral medullary chemosensitive areas: differential respiratory and cardiovascular effects.
      M A Hurlé, A Mediavilla and J Flórez
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 642-647;

  4. Meller, E

    1. Differential dose- and time-dependent effects of molindone on dopamine neurons of rat brain: mediation by irreversible inhibition of monoamine oxidase.
      E Meller and E Friedman
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 609-615;

  5. Miller, J M

    1. Opiates and thermoregulation in mice. II. Effects of opiate antagonists.
      C E Rosow, J M Miller, J Poulsen-Burke and J Cochin
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 464-467;
    2. Opiates and thermoregulation in mice. III. Agonist-antagonists.
      C E Rosow, J M Miller, J Poulsen-Burke and J Cochin
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 468-475;

  6. Miller, R J

    1. Neurohumoral control of ileal electrolyte transport. I. Bombesin and related peptides.
      J F Kachur, R J Miller, M Field and J Rivier
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 449-455;
    2. Neurohumoral control of ileal electrolyte transport. II. Neurotensin and substance P.
      J F Kachur, R J Miller, M Field and J Rivier
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 456-463;

  7. Moreton, J E

    1. Differential electroencephalographic and behavioral cross tolerance to morphine and methadone in the l-alpha-acetylmethadol (LAAM)-maintained rat.
      S E Lukas, J E Moreton and N Khazan
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 561-567;

  8. Morselli, P L

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
      P Worms, H Depoortere, A Durand, P L Morselli, K G Lloyd and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 660-671;

N

  1. Nakadate, T

    1. Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum.
      T Nakaki, T Nakadate, S Yamamoto and R Kato
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 637-641;

  2. Nakaki, T

    1. Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum.
      T Nakaki, T Nakadate, S Yamamoto and R Kato
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 637-641;

  3. Nau, H

    1. Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse.
      H Nau and W Löscher
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 654-659;

  4. Notley, B A

    1. Age-related changes in hepatic microsomal drug metabolism are substrate selective.
      L E Rikans and B A Notley
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 574-578;

O

  1. O'Callaghan, J P

    1. The effects of morphine on calcium-regulated phosphorylation of synaptosomal cytosolic proteins from rat striatum.
      J P O'Callaghan, J C Juskevich and W Lovenberg
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 696-702;

  2. Oates, J A

    1. Differential competition by L-alpha-methyldopa metabolites for adrenergic receptors in rat forebrain.
      M R Goldberg, C S Tung, R D Feldman, H E Smith, J A Oates and D Robertson
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 552-560;

P

  1. Pastoriza-Munoz, E

    1. Ultrafiltration of gentamicin and netilmicin in vivo.
      E Pastoriza-Munoz, D Timmerman, S Feldman and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 604-608;

  2. Portoghese, P S

    1. Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine.
      S J Ward, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 494-498;

  3. Poulsen-Burke, J

    1. Opiates and thermoregulation in mice. II. Effects of opiate antagonists.
      C E Rosow, J M Miller, J Poulsen-Burke and J Cochin
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 464-467;
    2. Opiates and thermoregulation in mice. III. Agonist-antagonists.
      C E Rosow, J M Miller, J Poulsen-Burke and J Cochin
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 468-475;

  4. Price, V F

    1. Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity.
      V F Price and D J Jollow
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 504-513;

  5. Prince, D A

    1. Effects of local anesthetic QX-314 on the membrane properties of hippocampal pyramidal neurons.
      B W Connors and D A Prince
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 476-481;

R

  1. Ramwell, P W

    1. Selective antagonism of prostaglandin F2 alpha-mediated vascular responses by N-dimethylamino substitution of prostaglandin F2 alpha.
      R B Stinger, T M Fitzpatrick, E J Corey, P W Ramwell, J C Rose and P A Kot
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 521-525;

  2. Rech, R H

    1. Dispositional without functional tolerance to the hypothermic effects of pentobarbital in the rat.
      R L Commissaris, D R Semeyn and R H Rech
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 536-539;

  3. Reynolds, D G

    1. Naloxone without transfusion prolongs survival and enhances cardiovascular function in hypovolemic shock.
      N J Gurll, D G Reynolds, T Vargish and R Lechner
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 621-624;
    2. Naltrexone improves survival rate and cardiovascular function in canine hemorrhagic shock.
      N J Gurll, D G Reynolds, T Vargish and R Lechner
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 625-628;

  4. Rikans, L E

    1. Age-related changes in hepatic microsomal drug metabolism are substrate selective.
      L E Rikans and B A Notley
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 574-578;

  5. Rivier, J

    1. Neurohumoral control of ileal electrolyte transport. I. Bombesin and related peptides.
      J F Kachur, R J Miller, M Field and J Rivier
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 449-455;
    2. Neurohumoral control of ileal electrolyte transport. II. Neurotensin and substance P.
      J F Kachur, R J Miller, M Field and J Rivier
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 456-463;

  6. Robertson, D

    1. Differential competition by L-alpha-methyldopa metabolites for adrenergic receptors in rat forebrain.
      M R Goldberg, C S Tung, R D Feldman, H E Smith, J A Oates and D Robertson
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 552-560;

  7. Rose, J C

    1. Selective antagonism of prostaglandin F2 alpha-mediated vascular responses by N-dimethylamino substitution of prostaglandin F2 alpha.
      R B Stinger, T M Fitzpatrick, E J Corey, P W Ramwell, J C Rose and P A Kot
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 521-525;

  8. Rosow, C E

    1. Opiates and thermoregulation in mice. II. Effects of opiate antagonists.
      C E Rosow, J M Miller, J Poulsen-Burke and J Cochin
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 464-467;
    2. Opiates and thermoregulation in mice. III. Agonist-antagonists.
      C E Rosow, J M Miller, J Poulsen-Burke and J Cochin
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 468-475;

  9. Rush, G F

    1. Renal cortical accumulation of phenobarbital in rats and rabbits: lack of correlation with induction of renal microsomal monooxygenases.
      C H Kuo, G F Rush and J B Hook
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 547-551;

S

  1. Scatton, B

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor.
      K G Lloyd, S Arbilla, K Beaumont, M Briley, G De Montis, B Scatton, S Z Langer and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 672-677;
    2. gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas.
      B Scatton, B Zivkovic, J Dedek, K G Lloyd, J Constantinidis, R Tissot and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 678-688;
    3. gamma-Aminobutyric acid (GABA) receptor stimulation. IV. Effect of progabide (SL 76002) and other GABAergic agents on acetylcholine turnover in rat brain areas.
      B Scatton and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 689-695;

  2. Seltzman, T P

    1. Immunoassay of racemic drugs: a problem of enantioselective antisera and a solution.
      C E Cook, T P Seltzman, C R Tallent and J D Wooten
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 568-573;

  3. Semeyn, D R

    1. Dispositional without functional tolerance to the hypothermic effects of pentobarbital in the rat.
      R L Commissaris, D R Semeyn and R H Rech
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 536-539;

  4. Slizgi, G R

    1. Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine.
      G R Slizgi and J H Ludens
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 585-591;

  5. Slotkin, T A

    1. Maturation of sympathetic neurotransmission in the rat heart. VIII. Slowed development of noradrenergic synapses resulting from hypothyroidism.
      C Lau and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 629-636;

  6. Smith, H E

    1. Differential competition by L-alpha-methyldopa metabolites for adrenergic receptors in rat forebrain.
      M R Goldberg, C S Tung, R D Feldman, H E Smith, J A Oates and D Robertson
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 552-560;

  7. Smith, J H

    1. Effects of vanadate on organic ion accumulation in rat renal cortical slices.
      J H Smith, W E Braselton, S R Tonsager, G H Mayor and J B Hook
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 540-546;

  8. Smith, T W

    1. Lack of interaction between digoxin and quinidine in cultured heart cells.
      J D Horowitz, W H Barry and T W Smith
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 488-493;

  9. Stinger, R B

    1. Selective antagonism of prostaglandin F2 alpha-mediated vascular responses by N-dimethylamino substitution of prostaglandin F2 alpha.
      R B Stinger, T M Fitzpatrick, E J Corey, P W Ramwell, J C Rose and P A Kot
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 521-525;

T

  1. Takemori, A E

    1. Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine.
      S J Ward, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 494-498;

  2. Tallent, C R

    1. Immunoassay of racemic drugs: a problem of enantioselective antisera and a solution.
      C E Cook, T P Seltzman, C R Tallent and J D Wooten
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 568-573;

  3. Timmerman, D

    1. Ultrafiltration of gentamicin and netilmicin in vivo.
      E Pastoriza-Munoz, D Timmerman, S Feldman and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 604-608;

  4. Tissot, R

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas.
      B Scatton, B Zivkovic, J Dedek, K G Lloyd, J Constantinidis, R Tissot and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 678-688;

  5. Tonsager, S R

    1. Effects of vanadate on organic ion accumulation in rat renal cortical slices.
      J H Smith, W E Braselton, S R Tonsager, G H Mayor and J B Hook
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 540-546;

  6. Tung, C S

    1. Differential competition by L-alpha-methyldopa metabolites for adrenergic receptors in rat forebrain.
      M R Goldberg, C S Tung, R D Feldman, H E Smith, J A Oates and D Robertson
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 552-560;

V

  1. Vargish, T

    1. Naloxone without transfusion prolongs survival and enhances cardiovascular function in hypovolemic shock.
      N J Gurll, D G Reynolds, T Vargish and R Lechner
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 621-624;
    2. Naltrexone improves survival rate and cardiovascular function in canine hemorrhagic shock.
      N J Gurll, D G Reynolds, T Vargish and R Lechner
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 625-628;

W

  1. Wang, M Y

    1. Aminoglycosides induce a phospholipidosis in the renal cortex of the rat: an early manifestation of nephrotoxicity.
      S Feldman, M Y Wang and G J Kaloyanides
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 514-520;

  2. Ward, S J

    1. Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine.
      S J Ward, P S Portoghese and A E Takemori
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 494-498;

  3. Will, J A

    1. Pharmacological alteration of antigen-induced contraction of pulmonary arteries isolated from the actively sensitized guinea pig.
      J M Hand, J A Will and C K Buckner
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 526-535;

  4. Wooten, J D

    1. Immunoassay of racemic drugs: a problem of enantioselective antisera and a solution.
      C E Cook, T P Seltzman, C R Tallent and J D Wooten
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 568-573;

  5. Worms, P

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
      P Worms, H Depoortere, A Durand, P L Morselli, K G Lloyd and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 660-671;

Y

  1. Yamamoto, S

    1. Alpha-2 adrenergic inhibition of intestinal secretion induced by prostaglandin E1, vasoactive intestinal peptide and dibutyryl cyclic AMP in rat jejunum.
      T Nakaki, T Nakadate, S Yamamoto and R Kato
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 637-641;

  2. Yang, H Y

    1. Evidence for a gamma-aminobutyric acid (GABA) mediation in the benzodiazepine inhibition of the release of Met5-enkephalin elicited by depolarization.
      L G Harsing, H Y Yang and E Costa
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 616-620;

Z

  1. Zivkovic, B

    1. gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas.
      B Scatton, B Zivkovic, J Dedek, K G Lloyd, J Constantinidis, R Tissot and G Bartholini
      Journal of Pharmacology and Experimental Therapeutics March 1982, 220 (3) 678-688;
Back to top

In this issue

Advertisement